Pablo Olivera

9PUBLICATIONS
21CO-AUTHORS
Medical mycologyMajor global burdens of diseasePredictive and prognostic markersMedical biotechnology diagnostics (incl. biosensors)Autoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Oct 07, 2026
Real-world effectiveness and predictors of need for extended induction of mirikizumab therapy in ulcerative colitis.

|Jan 29, 2025
Comparative Improvement in Health-Related Quality of Life With Advanced Therapies for Moderate-to-Severe Crohn's Disease: A Network Meta-Analysis.

Pablo A Olivera, María L Parks, Ignacio Zubiaurre

|Feb 05, 2024
Biomarkers That Predict Crohn's Disease Outcomes.

Pablo A Olivera, Mark S Silverberg

|Oct 14, 2023
Practical Management of Biosimilar Use in Inflammatory Bowel Disease (IBD): A Global Survey and an International Delphi Consensus.

Ferdinando D'Amico, Virginia Solitano, Fernando Magro

|Sep 22, 2023
Endoscopically Active Ulcerative Colitis Is Associated With Asymptomatic Atherosclerotic Vascular Disease: A Case-Control Study.

Juan Lasa, Ezequiel Nazario, Gonzalo De Sanctis

|Apr 11, 2023
Review article: Risk of cardiovascular events in patients with inflammatory bowel disease receiving small molecule drugs.

Pablo A Olivera, Juan S Lasa, Giovanni Peretto

Pageof 2

Frequent Collaborators

3 joint publications

Silvio Danese

2 joint publications

Laurent Peyrin-Biroulet

2 joint publications

Juan Sebastian Lasa

2 joint publications

Laura E Targownik